Shoulder Innovations, Inc.
SI
Positions held
Your positionsSI isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $372.45M | Enterprise value | — | Trailing P/E | 22.09 | Forward P/E | -11.32 |
| PEG | — | Price / book | 3.00 | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | strong_buy | Mean target | $26.25 |
| 52w high | $24.60 | 52w low | $10.92 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $17.2M | $16.7M | $14.4M | $11.8M | $11.0M | — |
| Op margin | -58.4% | -53.7% | -59.0% | -65.0% | -53.2% | — |
| Net income | -$10.2M | -$8.4M | -$7.8M | -$8.7M | -$19.2M | — |
| Gross margin | 78.3% | 77.7% | 76.7% | 76.2% | 76.2% | — |
| Gross profit | $13.4M | $13.0M | $11.1M | $9.0M | $8.4M | — |
| Operating income | -$10.0M | -$9.0M | -$8.5M | -$7.6M | -$5.9M | — |
- Revenue +3% vs prior quarter ($17M vs $17M).
- Gross margin 78.3% (was 77.7% prior quarter).
- Operating margin compressed to -58.4%.
Yearly (6y)
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $47.3M | $31.6M | $19.3M |
| Op margin | -55.6% | -46.3% | -56.4% |
| Net income | -$40.4M | -$15.6M | -$12.7M |
| Gross margin | 76.5% | 77.0% | 79.2% |
| Gross profit | $36.2M | $24.3M | $15.3M |
| Operating income | -$26.3M | -$14.7M | -$10.9M |
Headlines — watch
• [WARN · legal] Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience
News
2026-09-10 · Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch
2026-09-09 · Shoulder Innovations Collaborates With ALM Ortho to Introduce Implant for Shoulder Deformity
2026-09-08 · Shoulder Innovations Settles Patent Dispute With Catalyst OrthoScience
2026-09-08 · Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience
2026-09-01 · Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference
2026-08-18 · Shoulder Innovations Insider Sold Shares Worth $464,805, According to a Recent SEC Filing
2026-08-14 · UMH Properties and 4 More Stocks See Action From Activist Investors
2026-08-12 · Silver could surge to $90 as investment demand takes over, Citi says
2026-08-10 · Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer
2026-08-09 · Shoulder Innovations Q2 Earnings Call Highlights
2026-08-07 · Citadel Securities’ Rubner says it’s time to start buying gold again
Price (daily)
Full chart · RSI · MACD · patterns